Combination of Sorafenib and Cytokine-Induced Killer Cells in Metastatic Renal Cell Carcinoma: A Potential Regimen
Yonghao Yang(Army Medical University), Quanli Gao(Zhengzhou University), Lingdi Zhao(Zhengzhou University), Hongwei Lin(Zhengzhou University), Yongping Song(Zhengzhou University)
Cited by 9
Related Papers
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
|Science Immunology|2020|555
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
|Nature Immunology|2021|374
The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study
|Frontiers in Immunology|2021|73
Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy
|Leukemia|2017|56
High cumulative doxorubicin dose for advanced soft tissue sarcoma
|BMC Cancer|2020|41